Actinium-225
Actinium-225 from a radium-226 route.
Supplied to drug developers since 2024, with global distribution from Ionetix's purpose-built facility in Lansing, Michigan.
Ionetix produces actinium-225 (Ac-225) by proton bombardment of a radium-226 (Ra-226) target, on a cyclotron at its Lansing, Michigan facility. Radium-226 proton bombardment yields isotopically pure actinium-225 with no detectable actinium-227 (Ac-227) co-produced.
Since 2024, Ionetix has supplied actinium-225 to development programs in North America, Europe and Asia.
FAQ
Actinium-225 (Ac-225) is an alpha-emitting isotope with a half-life of 9.9 days, supplied to researchers and drug developers running targeted alpha therapy programs.
By proton bombardment of a radium-226 (Ra-226) target on a cyclotron at its facility in Lansing, Michigan, USA. This production route yields isotopically pure Ac-225 with no detectable actinium-227 (Ac-227) co-produced.
As actinium nitrate or actinium chloride.
To researchers and drug developers in North America, Europe and Asia since 2024.
Contact